Loading...
XNASBIOL
Market cap634kUSD
Oct 02, Last price  
0.02USD
Name

BIOLASE Inc

Chart & Performance

D1W1MN
XNAS:BIOL chart
P/E
—
P/S
0.01
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
174.27%
Rev. gr., 5y
1.27%
Revenues
49m
+1.45%
60,651,00061,980,00069,700,00066,889,00064,625,00043,347,00026,225,00048,858,00057,356,00056,430,00047,656,00048,475,00051,810,00046,926,00046,155,00037,799,00022,780,00039,188,00048,462,00049,164,000
Net income
-21m
L-27.95%
-23,214,000-17,510,000-4,689,000-7,280,000-9,129,000-2,956,000-12,021,000-4,486,000-3,056,000-11,482,000-18,926,000-20,278,000-15,371,000-16,851,000-21,516,000-17,855,000-16,829,000-16,158,000-28,634,000-20,632,000
CFO
-14m
L-47.35%
-1,571,000-17,051,000425,000-3,269,000-4,520,000-2,571,000-3,812,000-13,320,000-1,664,000-9,296,000-16,201,000-17,772,000-10,647,000-18,412,000-14,147,000-12,746,000-12,795,000-16,710,000-26,761,000-14,091,000
Dividend
Jun 24, 20050.0001 USD/sh
Earnings
Mar 19, 2025

Profile

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, such as cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, pain therapy, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces, and teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.
URL
https://www.biolase.com/
IPO date
Nov 12, 1992
Employees
188
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
49,164
1.45%
48,462
23.67%
39,188
72.03%
Cost of revenue
67,101
73,800
55,304
Unusual Expense (Income)
NOPBT
(17,937)
(25,338)
(16,116)
NOPBT Margin
Operating Taxes
31
109
65
Tax Rate
NOPAT
(17,968)
(25,447)
(16,181)
Net income
(20,632)
-27.95%
(28,634)
77.21%
(16,158)
-3.99%
Dividends
Dividend yield
Proceeds from repurchase of equity
9,553
5,602
29,979
BB yield
-666.22%
-12,436.45%
-130,070.78%
Debt
Debt current
3,153
700
405
Long-term debt
15,529
15,609
16,501
Deferred revenue
256
418
329
Other long-term liabilities
(1,531)
722
330
Net debt
12,116
12,128
(13,066)
Cash flow
Cash from operating activities
(14,091)
(26,761)
(16,710)
CAPEX
(1,311)
(3,727)
(707)
Cash from investing activities
(1,129)
(3,727)
(707)
Cash from financing activities
17,434
4,603
29,954
FCF
(14,360)
(30,640)
(15,631)
Balance
Cash
6,566
4,181
29,972
Long term investments
Excess cash
4,108
1,758
28,013
Stockholders' equity
(315,147)
(296,893)
(267,969)
Invested Capital
332,966
317,540
308,735
ROIC
ROCE
EV
Common stock shares outstanding
1,278
69
59
Price
1.12
72.62%
0.65
66.67%
0.39
-6.41%
Market cap
1,434
3,083.30%
45
95.44%
23
126.19%
EV
15,753
12,173
(13,009)
EBITDA
(15,139)
(24,841)
(15,716)
EV/EBITDA
0.83
Interest
2,361
2,749
2,224
Interest/NOPBT